AstraZeneca Cancer Drug Shows Early Signs of Promise in Covid-19

(Bloomberg) -- A small study in 19 people suggested a drug from AstraZeneca Plc’s arsenal of cancer treatments may be repurposed to help Covid-19 patients experiencing extreme immune reactions.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.